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A novel biomarker panel for triage of HPV 
positive women with high specificity for 
detection of clinically relevant cervical disease
Introduction
HR-HPV based primary cervical screening is 
now being implemented in several countries. 
Robust objective triage strategies for 
management of HR-HPV positive women are 
needed. 
The objective of this study was to identify 
proteins involved in innate immunity at epithelial 
surfaces which could be used as biomarkers to 
risk stratify HR-HPV positive women.
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Methods
Results
Samples- Liquid based cytology (LBC) samples
were obtained from both screening and colposcopy
populations from the Scottish HPV archive.
HPV typing was done using the Abbott rtHPV test.
Protein extraction was done using chloroform
isopropanol method (Canham et al, 2014).
Chemokine levels were measured using
ProcartaPlex kit (Affymetrix eBioscience, UK)
according to manufacturer’s guidelines.
Figure 1. Differences in chemokine proteins
between CIN3 and all other groups. Pooled
protein extracts from LBC samples (10mg of
protein from each of 9 women) from women with
different grades of disease and normal controls
were analysed using chemokine proteomic array
(R&D Systems, UK). Left- Each chemokine is
printed in duplicate in the array. Patients with
CIN3 showed a very different pattern of
chemokine expression from any other group.
Right– Expression level of chemokines in HR-






































































































Figure 2. Six chemokines are upregulated in HR-
HPV positive women with CIN2+. Results of a case
control study of LBC samples from HR-HPV positive
women with CIN2+ (cases, n-=268) and cytology
normal or CIN1 (controls, n=459) using ProcartaPlex
kit. Left- Barcharts indicating levels of protein, *** =
p<0.001 (Kruskal-Wallis test with Dunn’s multiple
comparison post-test). Right– Multivariate analysis
of different predictive models to assess sensitivity
(Sens), Specificity (Spec), Positive Predictive Value




























0 5000 10000 15000 20000
HPV+ve CIN3
CCL5
Sens Spec PPV NPV
CXCL1 55.5% 75.6% 68.8% 63.7%
CCL2 and CXCL1 65.5% 72.4% 69.6% 68.5%
CXCL1 and CXCL8 62.2% 76.4% 71.8% 67.6%
CCL2, CXCL1 and 
CXCL8 71.4% 65.0% 66.4% 70.2%
CCL2, CCL3, 
CCL4, CXCL1, 
CXCL8, CXCL12 67.2% 72.4% 70.2% 69.5%
Outcome
A panel of chemokines has been identified which could 
serve as an objective biomarker for HPV infection 
associated with CIN2+. This has potential as a triage 
strategy for HPV primary screening. 
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